BlackRock (BLK) Prices 28.753M Share Secondary Offering at $420/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- Wall St climbs after August inflation report, oil price slide
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but on track for 8% weekly gain on supply concerns; US diesel hits record high
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- White House copper tariff plan stalls amid affordability concerns, sources say
- Micron's Taiwan workers to get rewards worth up to 68 months of pay
- Crude Inventory 0.4M Barrels Last Week - EIA
- Vertiv shares drop on acquisition skepticism, AI pullback
- S&P 500, Dow futures attempt recovery ahead of inflation report
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
PNC Financial Services (PNC) is Said to Sell BlackRock (BLK) Stake at $420 Per Share - Bloomberg
May 12, 2020 5:38 PM EDTPNC Financial Services (NYSE: PNC) is Said to Sell BlackRock (NYSE: BLK) Stake at $420 Per Share - Bloomberg
... MorePre-Open Stock Movers 05/12: (CBAY) (NVAX) (IIVI) Higher; (GNFT) (STRO) (EB) Lower (more...)
May 12, 2020 9:11 AM EDTToday's Pre-Open Stock Movers:
CymaBay Therapeutics (NASDAQ: CBAY) 144.6% HIGHER; independent expert panel unanimously concludes there is no clinical, biochemical or histological evidence of seladelpar-induced liver injury in Phase 2b NASH study.
GENFIT (Nasdaq: GNFT) 50.7% LOWER; announced results from an interim analysis of the RESOLVE-IT Phase 3 trial evaluating once-daily, 120mg of elafibranor in adults with non-alcoholic steatohepatitis (NASH). The trial did not meet the predefined primary endpoint of NASH resolution without worsening of fibrosis in... More
BlackRock throws weight behind new NYSE and Nasdaq challenger MEMX
May 12, 2020 9:01 AM EDTBy John McCrank
NEW YORK (Reuters) - The Members Exchange on Tuesday said BlackRock Inc (NYSE: BLK), the world's biggest asset manager, was among its latest financial and strategic backers as the new bourse gears up to take on the New York Stock Exchange and Nasdaq Inc (NASDAQ: NDAQ) with a third-quarter launch.
MEMX, which was... More
After-Hours Stock Movers 05/11: (CBAY) (YRCW) (NVAX) Higher; (GNFT) (STRO) (EB) Lower (more...)
May 11, 2020 5:53 PM EDTToday's After-Hours Stock Movers:
CymaBay Therapeutics (CBAY) 119% HIGHER; independent expert panel unanimously concludes there is no clinical, biochemical or histological evidence of seladelpar-induced liver injury in Phase 2b NASH study.
GENFIT (Nasdaq: GNFT) 50.7% LOWER; announced results from an interim analysis of the RESOLVE-IT Phase 3 trial evaluating once-daily, 120mg of elafibranor in adults with non-alcoholic steatohepatitis (NASH). The trial did not meet the predefined primary endpoint of NASH resolution without worsening of fibrosis in the ITT population of 1,070 patients. The response rate in... More
BlackRock (BLK) Announces Secondary Offering of Its Common Stock Held by PNC; Plans $1.1 Billion Stock Repurchase
May 11, 2020 4:26 PM EDTBlackRock, Inc. (NYSE: BLK) (the Company) today announced the commencement of a secondary offering of its common stock through which The PNC Financial Services Group, Inc. (NYSE: PNC) intends to exit its full investment in the Company. The shares being offered by PNC will be sold in an underwritten public secondary offering. PNC also expects to grant the underwriters a 30-day option to purchase an... More
